VP and CFO of HiTech Pharmacal Co. Inc. (HITK, Financial) William J Peters sells 6,250 shares of HITK on 12/11/2009 at an average price of $22.62 a share.
Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace. Hitech Pharmacal Co. Inc. has a market cap of $276.8 million; its shares were traded at around $23.39 with a P/E ratio of 12.9 and P/S ratio of 2.5.
HITK is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES, Arnold Van Den Berg of Century Management, Bruce Kovner of Caxton Associates.
Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing branded and generic products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The Company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace. Hitech Pharmacal Co. Inc. has a market cap of $276.8 million; its shares were traded at around $23.39 with a P/E ratio of 12.9 and P/S ratio of 2.5.
HITK is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES, Arnold Van Den Berg of Century Management, Bruce Kovner of Caxton Associates.
CEO Recent Trades:
- Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 30,000 shares of HITK stock on 10/07/2009 at the average price of 23.45, the price of the stock has decreased by 0.26% since
- Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 40,000 shares of HITK stock on 09/29/2009 at the average price of 21.49, the price of the stock has increased by 8.84% since
- Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 153,776 shares of HITK stock on 09/15/2009 at the average price of 21.05, the price of the stock has increased by 11.12% since
- Sell:: CEO, President, Sec'y, Treas., 10% Owner David S Seltzer sold 16,224 shares of HITK stock on 07/16/2009 at the average price of 12.66, the price of the stock has increased by 84.76% since
CFO Recent Trades:
- Sell:: VP and CFO William J Peters sold 26,250 shares of HITK stock on 10/14/2009 at the average price of 25.05, the price of the stock has decreased by 6.63% since
- Sell:: VP and CFO William J Peters sold 10,800 shares of HITK stock on 09/30/2009 at the average price of 22.81, the price of the stock has increased by 2.54% since
- Sell:: VP and CFO William J Peters sold 56,250 shares of HITK stock on 09/11/2009 at the average price of 21.86, the price of the stock has increased by 7% since
Directors and Officers Recent Trades:
- Sell:: Director Bruce W Simpson sold 15,469 shares of HITK stock on 12/11/2009 at the average price of 23.29, the price of the stock has increased by 0.43% since
- Sell:: President, HCP Division Gary M April sold 58,125 shares of HITK stock on 12/11/2009 at the average price of 23.07, the price of the stock has increased by 1.39% since
- Sell:: Director Yashar Hirshaut sold 11,250 shares of HITK stock on 10/16/2009 at the average price of 24.5, the price of the stock has decreased by 4.53% since
- Sell:: Director Reuben Seltzer sold 35,916 shares of HITK stock on 10/15/2009 at the average price of 24.92, the price of the stock has decreased by 6.14% since
- Sell:: Director Martin M Goldwyn sold 1,000 shares of HITK stock on 09/30/2009 at the average price of 22.11, the price of the stock has increased by 5.79% since
